I2 Therapeutics

Aizen Therapeutics

This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.

Drug Delivery

This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.

Prolynx

The company develops long-acting medicines for obesity and metabolic conditions using proprietary drug delivery technology for patients requiring less frequent dosing.

Resalis Therapeutics

This company develops non-coding RNA therapies to treat metabolic disorders, including obesity and fatty liver disease, for patients with unmet medical needs.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

General Biotechnologies

This company develops genetically programmed edible microbes to manufacture oral peptide therapeutics for patients with metabolic diseases and other chronic conditions.

Intarcia Therapeutics

This biopharmaceutical company develops subcutaneous drug delivery implants for patients with chronic diseases such as type 2 diabetes and HIV.

Hawkhill Therapeutics

This company develops oral small molecule therapies for obesity and metabolic health to preserve muscle mass for the biotechnology and pharmaceutical sectors.